MedPath

The ICALIC International Multicentric Study

Completed
Conditions
Critical Illness
Interventions
Other: Time needed to start indirect calorimetry measurement
Other: Indirect calorimetry measurement
Registration Number
NCT02796430
Lead Sponsor
University Hospital, Geneva
Brief Summary

This study will evaluate the ease of use of the new calorimeter (Q-NRG (COSMED, Italy)) in intensive care unit (ICU) patients compared to currently used calorimeters (i.e. Quark RMR 1.0(COSMED, Italy) or Deltatrac Metabolic Monitor (Datex, Finland)), as well as the stability and the feasibility of the measurements in various clinically relevant situations.

Time needed to prepare and start indirect calorimetry (IC) measurement will be compared as the measure of the ease of use of the calorimeter.

Detailed Description

Background and Aims:

This study aims at evaluating the ease of use of the new calorimeter for the measurement of energy expenditure (EE) in intensive care unit (ICU) patients. EE in ICU patients is highly variable depending on the severity of the disease and treatments. Clinicians need to measure EE by indirect calorimetry (IC) to optimize nutritional support for the better clinical outcome. However, indirect calorimeters available on the market have insufficient accuracy for clinical and research use. Difficulties of handling and interpretation of results often limit IC in ICU patients. An accurate, easy-to-use calorimeter has been developed to meet these needs.

The Study Device:

The new calorimeter (Q-NRG, COSMED) is capable of IC measurements in mechanically ventilated patients without warm-up and limited calibration. The disposable in-line pneumotach flow meter and direct sampling of respiratory gas from the ventilator circuit enables the accurate measurement of oxygen consumption volume (VO2) and CO2 production volume (VCO2) to derive the energy expenditure. The software interface to manage the device and the collected data provides easy-to-use, user-friendly interface. Q-NRG does not bear the European Commission Conformity Mark (CE Mark), but has been approved by the Swiss authority for medical devices (Swissmedic) for use in this study. Q-NRG will be used in the way it is intended to be used as described in the instruction manual.

Currently used indirect calorimeters at each study center will be used as the comparator.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
272
Inclusion Criteria
  • Mechanically ventilated adult ICU patients
Exclusion Criteria
  • Fraction of inhaled oxygen (FIO2) > 70%
  • Positive end expiratory pressure (PEEP) >10cmH2O
  • Peak ventilatory pressure > 30cmH2O
  • Presence of air leaks from thoracic drain tube
  • Changes in vasoactive agent dose (>20%, <1 hr before and/or during IC)
  • Agitation or change in sedative dose (>20%, <1 hr before and/or during IC)
  • Change in body temperature (>0.5°C, <1 hr before and/or during IC)
  • Expected duration of ICU stay < 24 hours
  • Expected survival of the patient < 24 hours

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Mechanically ventilated patientsIndirect calorimetry measurementEase of use will be assessed by analysing the time needed to start indirect calorimetry measurement, and results of indirect calorimetry measurements by both the new indirect calorimeter and the currently used calorimeters at each study center.
Mechanically ventilated patientsTime needed to start indirect calorimetry measurementEase of use will be assessed by analysing the time needed to start indirect calorimetry measurement, and results of indirect calorimetry measurements by both the new indirect calorimeter and the currently used calorimeters at each study center.
Primary Outcome Measures
NameTimeMethod
Time needed to start indirect calorimetry (IC) measurement in Q-NRG compared to currently used calorimetersimmediately after the measurement

Time from the start-up of the devices until the 1st recorded measurement will be measured and compared between Q-NRG and the currently used indirect calorimeters, including time needed for patient information input, warm-up and calibrations according to the instructions for the devices, and installation of the device components needed for the measurements on patients.

Secondary Outcome Measures
NameTimeMethod
Comparison of energy expenditure(EE) from Q-NRG and currently used calorimetersimmediately after the measurement

EE measured by Q-NRG and currently used calorimeters will be compared to identify the differences of the characteristics of the measurements according to the different types of calorimeters.

CV of EE when measured in different levels of patient severityimmediately after the measurement

CV of EE measured by the Q-NRG in different levels of patient severity will be analyzed to evaluate the difference in the stability of the measurement according to various levels of severity.

Coefficient of variation (CV) of EE for different mechanical ventilatorsimmediately after the measurement

CV of EE measured by Q-NRG when using different mechanical ventilators will be analyzed to evaluate the effects of the mechanical ventilators used during the indirect calorimetry measurement.

CV of EE when using different ventilation modesimmediately after the measurement

CV of EE measured by Q-NRG when using different mechanical ventilation modes will be analyzed to evaluate the effect of different mechanical ventilation modes used during the indirect calorimetry measurement.

CV of EE in various ranges of oxygen and airway pressure supportimmediately after the measurement

CV of EE measured by the Q-NRG in different ranges of FiO2 will be analyzed to evaluate the difference in the stability of the measurements according to various FiO2 ranges.

CV of EE when measured in different sedation/consciousness levelsimmediately after the measurement

CV of EE measured by the Q-NRG in different levels of sedation/consciouness will be analyzed to evaluate the difference in the stability of the measurements according to various sedation/consciousness levels.

Trial Locations

Locations (7)

Department of Anesthesiology and Intensive Care Medicine, Karolinska University Hospital

🇸🇪

Huddinge, Sweden

Critical Care Medicine, Institute for Nutrition Research, Rabin Medical Center, Beilison Hospital

🇮🇱

Petah Tikva, Israel

Service of Intensive Care, Geneva University Hospital

🇨🇭

Geneva, Switzerland

Adult Intensive care, Lausanne University Hospital

🇨🇭

Lausanne, Switzerland

Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine

🇦🇹

Vienna, Austria

Department of Intensive Care, Vrije Universiteit Brussel

🇧🇪

Brussels, Belgium

Chiba University Hospital

🇯🇵

Chiba, Japan

© Copyright 2025. All Rights Reserved by MedPath